---
type: "Topics"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/topics/43179247.md"
description: "$昭衍新藥(06127.HK)、$德適-B(02526.HK)、$三葉草生物-B(02197.HK)、$德康醫療(DXCM.US)、$京東健康(06618.HK)——從臨牀前 CRO 到基因診斷到疫苗到血糖監測再到賣藥平台，醫療這條鏈上每一段的賺錢方式都不一樣。"
datetime: "2026-08-04T10:18:25.000Z"
locales:
  - [en](https://longbridge.com/en/topics/43179247.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/43179247.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/43179247.md)
author: "[躺平房东林叔](https://longbridge.com/zh-HK/profiles/26419403.md)"
generator: "portal-rs"
---

# $昭衍新藥(06127.HK)、$德適-B(02526.HK)、$三葉草生物-B(02197.HK)…


### 相關股票

- [DXCM.US](https://longbridge.com/zh-HK/quote/DXCM.US.md)
- [06618.HK](https://longbridge.com/zh-HK/quote/06618.HK.md)
- [06127.HK](https://longbridge.com/zh-HK/quote/06127.HK.md)
- [02526.HK](https://longbridge.com/zh-HK/quote/02526.HK.md)
- [02197.HK](https://longbridge.com/zh-HK/quote/02197.HK.md)
- [86618.HK](https://longbridge.com/zh-HK/quote/86618.HK.md)
- [603127.CN](https://longbridge.com/zh-HK/quote/603127.CN.md)

---
> **免責聲明: 本文僅供參考，不構成任何投資建議。**